Falcon Point Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Falcon Point Capital’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,854	Closed	-$385K	–	114
2016 Q2	$385K	Buy	4,854 +539	+12%	+$46.7K	0.07%	92
2016 Q1	$328K	Buy	4,315 +2,118	+96%	+$135K	0.06%	103
2015 Q4	$197K	Sell	2,197 -624	-22%	-$59.9K	0.04%	113
2015 Q3	$316K	Buy	+2,821	New	+$325K	0.11%	103

Other funds holding PLXP

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Falcon Point Capital's PLXP Position: Q3 2016 in Review

Falcon Point Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 4,854 shares — an estimated $385K sold.

Falcon Point Capital first reported a position in PLXP in Q3 2015 and held it in 4 quarters. The position peaked at $385K in Q2 2016. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

Falcon Point Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Falcon Point Capital sold 4,854 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $385K.
Falcon Point Capital first reported a position in PLx Pharma Inc. Common Stock in Q3 2015 and held it in 4 quarters.
Falcon Point Capital's PLx Pharma Inc. Common Stock position peaked at $385K in Q2 2016.
32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Falcon Point Capital's 13F filing for Q3 2016, filed 8 Nov 2016.